Expanding our MS portfolio for your Clinical & Forensic Toxicology Challenges!

Tuesday  June 1st 2021, 11:30

Clinical & Forensic Toxicology Challenges

  • Screening solutions based on UPLC-QDa
  • Screening and confirmation methods using the high sensitivity UPLC-Xevo TQ-S Micro
  • Elucidation of NPS and real unknown screening by the UNIFI HRMS Xevo G2-XS Q-TOF solution
  • Direct Analysis of Seized drugs by the NEW RADIAN

Registration
WATERS MS PORTFOLIO

Clinical & Forensic Toxicology Challenges

Best Regards
Michael Kontogiannis
Managing Director

Newsletter

Sign up to Hellamco's Mailing List and check out our latest news.
HELLAMCO S.A. will process your personal data only for communication and updating purposes, will not distribute them on to third parties and will keep them in the database for 30 days. For more information regarding the processing of personal data and rights, please visit our relative privacy policy.